Recurrence and outcomes of non‐functional pancreatic neuroendocrine tumours post‐resection: an Australian retrospective, multicentre cohort study

Pancreatic neuroendocrine tumours (PNETs) are heterogenous entities with variable clinical outlook. The prevalence of PNETs is increasing in Australia. Despite this, data on peri‐operative management and post‐operative prognosis for Australian patients is scant in the literature.

[1]  T. Pawlik,et al.  Identifying Risk Factors and Patterns for Early Recurrence of Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study , 2021, Cancers.

[2]  Fei Li,et al.  Head and body/tail pancreatic neuroendocrine tumors have different biological characteristics and clinical outcomes , 2020, Journal of Cancer Research and Clinical Oncology.

[3]  Xubao Liu,et al.  Analysis of recurrence after resection of well-differentiated non-functioning pancreatic neuroendocrine tumors , 2020, Medicine.

[4]  T. Pawlik,et al.  Resection of pancreatic neuroendocrine tumors: defining patterns and time course of recurrence. , 2020, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[5]  Jin‐Young Jang,et al.  Validation of the 8th AJCC Cancer Staging System for Pancreas Neuroendocrine Tumors Using Korean Nationwide Surgery Database , 2019, Cancer research and treatment : official journal of Korean Cancer Association.

[6]  K. Chouliaras,et al.  Analysis of recurrence after the resection of pancreatic neuroendocrine tumors , 2018, Journal of surgical oncology.

[7]  A. Scarpa,et al.  Patterns of Recurrence after Resection for Pancreatic Neuroendocrine Tumors: Who, When, and Where? , 2018, Neuroendocrinology.

[8]  Shouhao Zhou,et al.  Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States , 2017, JAMA oncology.

[9]  D. Gouma,et al.  The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After , 2017, Surgery.

[10]  Xiao‐Yu Yin,et al.  Surgery management for sporadic small (≤2 cm), non-functioning pancreatic neuroendocrine tumors: a consensus statement by the Chinese Study Group for Neuroendocrine Tumors (CSNET). , 2017, International journal of oncology.

[11]  Michael M Maher,et al.  Computed tomography and patient risk: Facts, perceptions and uncertainties , 2016, World journal of radiology.

[12]  H. S. King,et al.  Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle- and high-income countries , 2016, British journal of anaesthesia.

[13]  R. Jensen,et al.  ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors , 2016, Neuroendocrinology.

[14]  R. Yu,et al.  Pancreatic neuroendocrine tumors: biology, diagnosis, and treatment , 2013, Chinese journal of cancer.

[15]  M. Koch,et al.  Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. , 2011, Surgery.

[16]  Abe Fingerhut,et al.  Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. , 2007, Surgery.

[17]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[18]  OUP accepted manuscript , 2022, The Oncologist.